USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
CYTEL, INC
Address:
675 MASSACHUSETTS AVE
CAMBRIDGE, MA 02139
Phone:
N/A
URL:
EIN:
104295567
DUNS:
183012277
Number of Employees:
400
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $396,596.00 3
SBIR Phase II $2,742,673.00 3

Award List:

FACILITATING THE TRANSFER OF STATISTICAL METHODOLOGY INTO PRAC

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Cyrus Mehta – (617) 661-2011
Abstract:
The goal of this project is to develop a prototype software for some basic parametric and nonparametric multiple comparison procedures allowing the analysis of clinical trials data by multiple comparison procedures that guarantee strong control of the family wise error rate (FWER). Regulators at the… More

Exact Statistical Tools for Genetic Association Studies

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$112,075.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The overall goal of our research is to develop and extend powerful exact statistical tools for testing genetic association, and to incorporate these methods into two existing, widely used software packages (Cytel Studio , SAS) that will serve the needs of data… More

Statistical Software for Adaptive Oncology Clinical Trials

Award Year / Program / Phase:
2010 / SBIR / Phase I
Award Amount:
$184,521.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Two recent scientific developments, one in biostatistics and one in pharmacogenomics are likely to have a major impact on the design and monitoring of phase III and seamless phase II/III oncology trials, greatly improvi ng their chances of success. Advances in… More

New Methods to reduce Bias and Mean Square Error of Maximum Likelihood Estimators

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$996,640.00
Agency:
HHS
Principal Investigator:
Pralay Senchaudhuri – 617-661-2011
Abstract:
DESCRIPTION (provided by applicant): Categorical outcomes are ubiquitous in biomedical research, and generalized linear models (GLMs) represent the most widely applied methodology for testing associations between categorical variables and fixed investigative factors. Logistic regression in… More

IGF::OT::IGF OTHER FUNCTIONS RandD- MEDICAL: BIOMEDICAL (BASIC RESEARCH), STATISTICAL SOFTWARE FOR MULTIPLE COMPARISON PROCEDURES

Award Year / Program / Phase:
2012 / SBIR / Phase II
Award Amount:
$750,000.00
Agency:
HHS
Principal Investigator:
Cyrus Mehta – 617-661-2011
Abstract:
The Phase II SBIR contract proposal addresses a problem of fundamental importance for the design and analysis of Phase 3 randomized clinical trials. Over the past decade the design of such trials has been complicated by the desire to ask more than one question, within a single trial, concerning the… More

Exact Statistical Tools for Genetic Association Studies

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$996,033.00
Agency:
HHS
Principal Investigator:
Pralay Senchaudhuri – 617-661-2011
Abstract:
DESCRIPTION (provided by applicant): The overall goal of our research is to develop and extend efficient exact statistical tools for testing genetic association, and to incorporate these methods into existing, widely used software packages that will servethe needs of data analysts in… More